- Home
- / Timber Pharmaceuticals
Timber Pharmaceuticals
Stock Price
$0
2024-01-30
Market Capitalization
$1.2 M
2024-01-30
Revenue
$83.2 K
FY, 2022
Timber Pharmaceuticals Summary
Company Summary
- Overview
- Timber Pharmaceuticals is a company developing treatments for unmet needs in rare/orphan dermatology. It has a particular focus on rare diseases or conditions of the skin for which there are no approved treatments.
- Type
- Public
- Status
- Active
- Founded
- 2019
- HQ
- Basking Ridge, NJ, US | view all locations
- Website
- https://www.timberpharma.com
- Cybersecurity rating
Table of Contents
Key People
John Koconis, Chief Executive Officer and Director
Zachary Rome, Chief Operating Officer, Co-Founder and Director
Joseph Lucchese, Chief Financial Officer and Director
LocationsView all
1 location detected
Basking Ridge, NJ HQ
United States
110 Allen Rd
Timber Pharmaceuticals Financials
Summary Financials
- Net income (Q2, 2023)
- ($4.1M)
- Cash (Q2, 2023)
- $2.5M
- EBIT (Q2, 2023)
- ($4.0M)
- Enterprise value
- ($798.3K)